Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Appointed director
CC transcript
Auditor change
Acorda Therapeutics, Inc. (ACOR) Create: Alert

All | News | Filings
Date FiledTypeDescription
05/02/2018 BW Acorda Provides Financial and Pipeline Update for First Quarter 2018
04/11/2018 BW Acorda First Quarter Update: Webcast/Conference Call Scheduled for May 2, 2018
03/13/2018 BW Acorda Therapeutics to Present at Oppenheimer Healthcare Conference
02/15/2018 BW Acorda Provides Financial and Pipeline Update for Fourth Quarter and Year End 2017
02/02/2018 BW Acorda Fourth Quarter/Year End 2017 Update
12/26/2017 BW Acorda Therapeutics to Present at the 36th Annual J.P. Morgan Healthcare Conference
11/15/2017 BW Acorda Provides Update on Tozadenant Development Program
10/31/2017 BW Acorda Provides Financial and Pipeline Update for Third Quarter 2017
09/13/2017 BW Acorda to Present at the Cantor Fitzgerald Global Healthcare Conference
09/01/2017 BW Acorda Adopts Shareholder Rights Plan
07/27/2017 BW Acorda Provides Financial and Pipeline Update for Second Quarter 2017
07/13/2017 BW Acorda Second Quarter 2017 Update Webcast/Conference Call Scheduled for July 27, 2017
06/05/2017 BW CVT-301 Phase 3 Data Showed Significantly Improved Motor Function During OFF Periods in Parkinson??s Disease
05/31/2017 BW Acorda to Present at the Goldman Sachs Healthcare Conference
05/02/2017 BW Acorda to Present at the Deutsche Bank 42nd Annual Healthcare Conference
04/27/2017 BW CORRECTING and REPLACING Acorda Provides Financial and Pipeline Update for First Quarter 2017
04/27/2017 BW Acorda Provides Financial and Pipeline Update for First Quarter 2017
04/13/2017 BW Acorda to Host Conference Call to Discuss First Quarter 2017 on April 27, 2017
02/14/2017 BW Acorda Provides Financial and Pipeline Update for Fourth Quarter and Year End 2016
02/03/2017 BW Acorda Therapeutics to Present at Two Investor Conferences in February
01/31/2017 BW Acorda to Host Conference Call to Discuss Fourth Quarter 2016 on February 14, 2017
08/15/2011 BW Acorda Therapeutics Joins NY BioHud Valley as Founding Member
07/01/2011 BW Acorda Therapeutics Licenses Rights to Investigational Treatment for Spinal Cord Injury and Traumatic Brain Injury
06/30/2011 BW Acorda Therapeutics Wins Telly Awards in Documentary and Public Relations Categories
06/27/2011 BW Acorda Therapeutics to Relocate Corporate Headquarters to Ardsley Park Life Science Campus; Site Acquired and Now Managed by BioMed Realty Trust
06/24/2011 BW Acorda Therapeutics Wins Two 2011 Stevie Awards at the 9th Annual American Business Awards
06/06/2011 BW New Clinical Data Analysis of AMPYRA® (Dalfampridine) Shows Improvement of Patient-Reported Walking Ability across a Range of Walking Impairment
05/20/2011 BW Acorda Therapeutics Statement on CHMP Positive Opinion on Marketing Authorization Application for FAMPYRA® in Europe
05/09/2011 BW Acorda Therapeutics Recognized as One of the Best Places to Work in New York State
05/05/2011 BW Acorda Therapeutics Reports First Quarter 2011 Financial Results
04/28/2011 BW Acorda Therapeutics Ranked Fifth in The Scientist Best Places to Work in Industry 2011 Survey
04/28/2011 BW Acorda Therapeutics to Host Conference Call to Report First Quarter 2011 Financial Results on May 5, 2011
04/20/2011 BW Acorda Therapeutics Announces Changes to Board of Directors
04/19/2011 BW Acorda Therapeutics Announces Allowance of U.S. Patent Application for AMPYRA® (dalfampridine) Covering Methods of Use for Improving Walking in Multiple Sclerosis
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy